Details of the Drug

General Information of Drug (ID: DMAWLVB)

Drug Name
TPI ASM8
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 2 [1]
Therapeutic Class
Antisense
Drug Type
Antisense drug
Cross-matching ID
TTD ID
D02RPP

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 3 receptor (CSF2RB) TTPYS82 IL3RB_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01158898) Efficacy of TPI ASM8 During a 14-Day Allergen Challenge. U.S. National Institutes of Health.
2 Target mRNA inhibition by oligonucleotide drugs in man. Nucleic Acids Res.2012 Nov;40(21):10585-95.